Börsennachrichten

Truist senkt Kursziel für Fifth Third Bancorp (FITB), bestätigt Bewertung mit Kaufen

Truist Lowers PT on Fifth Third Bancorp (FITB), Keeps a Buy Rating

The panel's net takeaway is that Truist's price target cut for FITB reflects concerns about slowing loan growth, net interest …

JD.com (JD) und BYD Gehen Eine Strategische Partnerschaft Ein

JD.com (JD) and BYD Enters a Strategic Partnership

The panel views JD.com's partnership with BYD as a strategic move that leverages JD's logistics footprint and BYD's EV and …

Morgan Stanley hält eine Kaufempfehlung für Block (XYZ)

Morgan Stanley Maintains a Buy on Block (XYZ)

The panel is largely bearish on Block (SQ), citing risks such as potential loss of institutional memory from significant headcount …

Die $2.000-Dollar-Arzneimittelobergrenze spart Rentnern der Medicare über $1.500 pro Jahr

The $2,000 Drug Cap Is Saving Medicare Retirees Over $1,500 a Year Right Now

The $2,000 Part D cap provides significant relief for high-cost drug users but may have unintended consequences. While it increases …

Huntington Bancshares (HBAN) präsentiert auf der RBC 2026 Konferenz, hier ist, was Sie wissen sollten

Huntington Bancshares (HBAN) Presents at RBC 2026 Conference, Here’s What You Should Know

The panel's net takeaway is that HBAN's guidance is solid but faces significant risks, particularly around deposit betas, merger accounting, …

Stellantis (STLA) erwägt Partnerschaften mit chinesischen Automobilherstellern

Stellantis (STLA) Considering Partnerships With Chinese Automakers

The panel consensus is that Stellantis' exploration of partnerships with Chinese OEMs is a desperate move to address its European …

U.S. Aktien steigen deutlich von den schlechtesten Kursen ab, schliessen aber dennoch tiefer

U.S. Stocks Climb Well Off Worst Levels But Still Close Lower

The panelists agree that the market's resilience despite geopolitical tensions is deceptive, with energy infrastructure damage posing a significant risk …

Wie schneidet die Aktienperformance von Baxter im Vergleich zu anderen Medizintechnikaktien ab?

How Is Baxter's Stock Performance Compared to Other Medical Devices Stocks?

The panel consensus is bearish on Baxter (BAX), citing persistent margin pressure, operational struggles, and a high debt load. While …

G2 Investment Partners Initiates a New Position in Xometry

Despite impressive revenue growth, XMTR's significant net losses and unclear path to profitability remain a concern, with varying opinions on …

SBSW macht deutlichen Cross unter kritischem gleitenden Durchschnitt

SBSW Makes Notable Cross Below Critical Moving Average

The panel consensus is bearish on Sibanye Stillwater (SBSW) due to its sensitivity to PGM prices, South African operational risks, …

BioMarin Pharmaceutical (BMRN) berichtet über positive Ergebnisse aus laufenden Studien zu VOXZOGO

BioMarin Pharmaceutical (BMRN) Reports Positive Results From Ongoing Trials of VOXZOGO

The panel discusses BioMarin's VOXZOGO (vosoritide) data, with mixed views on its commercial potential. Bulls highlight label expansion to infants …

Wird Griechenlands neues Luftabwehrsystem den Aktienkurs von Lockheed Martin ankurbeln?

Will Greece's New Air Defense Plan Boost Lockheed Martin's Stock?

The panel generally agrees that the $36B Greece deal for Lockheed Martin (LMT) is geopolitically important but economically modest, with …